What's New?
HKAPI Virtual Engagement Guidance
November 4, 2020
In its Extraordinary General Meeting held on 4 November 2020, the HKAPI has passed a motion to adopt a set of Guidance on Virtual Engagements with Health Care Professionals to address the situations involving the provision of meals during virtual conferences and the dissemination of promotional materials and scientific information via electronic tools.
Senior Executive Director takes top honour at APEC 2020 Lighthouse Award
October 13, 2020
Senior Executive Director of Hong Kong Association of Pharmaceutical Industry, has been awarded APEC 2020 Lighthouse Award #Business Ethics for SMEs.
World Rare Disease Day 2020 Online Symposium
October 17, 2020
Our task force leads Karen Yuen and Sui Wong joined the “World Rare Disease Day 2020 Online Symposium” organized by Rare Disease Hong Kong (RDHK), formerly known as “Hong Kong Alliance for Rare Diseases (HKARD)”.
HKAPI Policy Address Recommendation 2020
September 2, 2020
The Hong Kong Association of the Pharmaceutical Industry (HKAPI) submits this opinion paper, on behalf of its 33 member companies engaging in the research and development of novel pharmaceuticals, and providing 70% of treatment drugs in Hong Kong.
Mission Statement
To drive the expedient access to innovative healthcare solutions for the people of Hong Kong and Macao with high ethical standard.